The medical supply distributor raised about $6.26 billion in a blockbuster IPO on Tuesday.
ByZachary Folk
ByZachary Folk,
Forbes Staff.
Medical supply firm Medline’s stock price rose around 30% on Wednesday after debuting on the Nasdaq, after raising $6.26 billion on Tuesday for the largest initial public offering of the year.
Medline’s shares were trading at $37.91 on Wednesday afternoon, up 30% after opening at $35 per share.
Medline priced at $29 per share on Tuesday, raising $6.26 billion to cap off a strong year for new listings and bolster optimism…
The share price of medical supplies titan Medline rose by 40% during Wednesday's trading on the first day of its initial public…
CNBC's Jim Cramer reviewed Medline, a medical supplies giant that made its market debut Wednesday.
La società, partecipata da Blackstone, Carlyle Group e Hellman & Friedman, ha collocato 216 milioni di azioni a 29 dollari per…
Medline CEO Jim Boyle joins 'Squawk Box' to discuss the company's IPO, the private equity involved and much more.
In this week’s edition of InnovationRx, Medline’s blockbuster IPO, Fred Moll’s surgical robotics investments, Forbes' inaugural…
Medline stock is a little too expensive to buy post IPO, Jim Cramer says
